<?xml version="1.0" encoding="UTF-8"?>
<rss version="2.0"
	xmlns:content="http://purl.org/rss/1.0/modules/content/"
	xmlns:wfw="http://wellformedweb.org/CommentAPI/"
	xmlns:dc="http://purl.org/dc/elements/1.1/"
	xmlns:atom="http://www.w3.org/2005/Atom"
	xmlns:sy="http://purl.org/rss/1.0/modules/syndication/"
	xmlns:slash="http://purl.org/rss/1.0/modules/slash/"
	>

<channel>
	<title>PILMAN &#187; recipe</title>
	<atom:link href="http://www.tapanray.in/tag/recipe/feed/" rel="self" type="application/rss+xml" />
	<link>http://www.tapanray.in</link>
	<description>A Tapan Ray Website</description>
	<lastBuildDate>Sun, 22 Mar 2026 10:59:18 +0000</lastBuildDate>
	<language>en-US</language>
	<sy:updatePeriod>hourly</sy:updatePeriod>
	<sy:updateFrequency>1</sy:updateFrequency>
	<generator>http://wordpress.org/?v=3.4.2</generator>
		<item>
		<title>Draft National Pharmaceutical Pricing Policy 2011: A flawed recipe</title>
		<link>http://www.tapanray.in/draft-national-pharmaceutical-pricing-policy-2011-a-flawed-recipe/?utm_source=rss&#038;utm_medium=rss&#038;utm_campaign=draft-national-pharmaceutical-pricing-policy-2011-a-flawed-recipe</link>
		<comments>http://www.tapanray.in/draft-national-pharmaceutical-pricing-policy-2011-a-flawed-recipe/#comments</comments>
		<pubDate>Mon, 28 Nov 2011 00:00:08 +0000</pubDate>
		<dc:creator>Tapan Ray</dc:creator>
				<category><![CDATA[Pharma]]></category>
		<category><![CDATA[2011]]></category>
		<category><![CDATA[Access]]></category>
		<category><![CDATA[Affordability]]></category>
		<category><![CDATA[DoP]]></category>
		<category><![CDATA[Draft]]></category>
		<category><![CDATA[flawed]]></category>
		<category><![CDATA[National]]></category>
		<category><![CDATA[NPPA]]></category>
		<category><![CDATA[NPPP2011]]></category>
		<category><![CDATA[pharmaceutical]]></category>
		<category><![CDATA[Policy]]></category>
		<category><![CDATA[Pricing]]></category>
		<category><![CDATA[Ray]]></category>
		<category><![CDATA[recipe]]></category>
		<category><![CDATA[Tapan]]></category>

		<guid isPermaLink="false">http://tapanray.in/index.php/?p=168</guid>
		<description><![CDATA[The ‘Drug Price’ has always remained one of the critical factors to ensure greater access to medicines, especially in the developing economies like India, where predominantly individuals are the payers. This point has also been widely accepted by the international &#8230; <a href="http://www.tapanray.in/draft-national-pharmaceutical-pricing-policy-2011-a-flawed-recipe/">Continue reading <span class="meta-nav">&#8594;</span></a>]]></description>
		<wfw:commentRss>http://www.tapanray.in/draft-national-pharmaceutical-pricing-policy-2011-a-flawed-recipe/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>Changing recipe for growth in the new paradigm of Indian Pharmaceutical Industry&#8230; for its effective implementation there appears to be more questions than answers:</title>
		<link>http://www.tapanray.in/changing-recipe-for-growth-in-the-new-paradigm-of-indian-pharmaceutical-industry-for-its-effective-implementation-there-appears-to-be-more-questions-than-answers/?utm_source=rss&#038;utm_medium=rss&#038;utm_campaign=changing-recipe-for-growth-in-the-new-paradigm-of-indian-pharmaceutical-industry-for-its-effective-implementation-there-appears-to-be-more-questions-than-answers</link>
		<comments>http://www.tapanray.in/changing-recipe-for-growth-in-the-new-paradigm-of-indian-pharmaceutical-industry-for-its-effective-implementation-there-appears-to-be-more-questions-than-answers/#comments</comments>
		<pubDate>Thu, 16 Jul 2009 01:30:43 +0000</pubDate>
		<dc:creator>Tapan Ray</dc:creator>
				<category><![CDATA[Pharma]]></category>
		<category><![CDATA[changing]]></category>
		<category><![CDATA[for]]></category>
		<category><![CDATA[growth]]></category>
		<category><![CDATA[in]]></category>
		<category><![CDATA[Indian]]></category>
		<category><![CDATA[industry]]></category>
		<category><![CDATA[New]]></category>
		<category><![CDATA[of]]></category>
		<category><![CDATA[paradigm]]></category>
		<category><![CDATA[pharmaceutical]]></category>
		<category><![CDATA[Ray]]></category>
		<category><![CDATA[recipe]]></category>
		<category><![CDATA[Tapan]]></category>
		<category><![CDATA[the]]></category>

		<guid isPermaLink="false">http://tapanray.in/index.php/?p=833</guid>
		<description><![CDATA[India, the world&#8217;s largest democracy with its economy on a sustained growth track is creating an overall environment for high performance for all key sectors, including pharmaceuticals. In terms of GDP growth India is second only to China and is &#8230; <a href="http://www.tapanray.in/changing-recipe-for-growth-in-the-new-paradigm-of-indian-pharmaceutical-industry-for-its-effective-implementation-there-appears-to-be-more-questions-than-answers/">Continue reading <span class="meta-nav">&#8594;</span></a>]]></description>
		<wfw:commentRss>http://www.tapanray.in/changing-recipe-for-growth-in-the-new-paradigm-of-indian-pharmaceutical-industry-for-its-effective-implementation-there-appears-to-be-more-questions-than-answers/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
	</channel>
</rss>
